About Caponex Labs
Caponex Labs is a company based in Hyderabad (India) founded in 2020 by S Madi Reddy. Caponex Labs has raised $278.67 thousand across 1 funding round from investors including Balvinder Singh Thakkar and Ravinder Singh Thakkar. The company has 1 employees as of April 10, 2024. Caponex Labs operates in a competitive market with competitors including Pharmaron, Lonza, Pfizer, Boehringer Ingelheim and LabConnect, among others.
- Headquarter Hyderabad, India
- Employees 1 as on 10 Apr, 2024
- Founders S Madi Reddy
-
Sectors
Chemicals & MaterialsHealthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Caponex Labs Private Limited
- Date of Incorporation 08 Aug, 2020
- Jurisdiction Hyderabad, Telangana, India
-
Annual Revenue
$317.22 K (USD)959.12as on Mar 31, 2023
-
Net Profit
-$443.09 K (USD)-124.84as on Mar 31, 2023
-
EBITDA
$166.54 K (USD)679.32as on Mar 31, 2023
-
Total Equity Funding
$278.67 K (USD)
in 1 rounds
-
Latest Funding Round
$278.67 K (USD), Angel Round
Mar 20, 2023
-
Investors
& 1 more
-
Employee Count
1
as on Apr 10, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Caponex Labs
Caponex Labs has successfully raised a total of $278.67K through 1 strategic funding round. The most recent funding activity was a Angel Round of $278.67 thousand completed in March 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Caponex Labs
Caponex Labs has secured backing from 2 investors, including angel investors. Prominent investors backing the company include Balvinder Singh Thakkar and Ravinder Singh Thakkar.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
BS
Balvinder Singh Thakkar |
-
|
Locked | Locked | Locked |
|
RS
Ravinder Singh Thakkar |
-
|
Locked | Locked | Locked |
Investor details for Caponex Labs
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Caponex Labs
Investment portfolio details for Caponex Labs
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Caponex Labs
Detailed financials for Caponex Labs
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Caponex Labs Comparisons
Peer comparison for Caponex Labs
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Caponex Labs
Caponex Labs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Pharmaron, Lonza, Pfizer, Boehringer Ingelheim and LabConnect, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Drug discovery and development services for small molecules are provided.
|
|
| Locked | Locked | Locked |
CDMO services for pharma, biotech, and specialty ingredients are provided.
|
|
| Locked | Locked | Locked |
Pharmaceutical products for treating multiple diseases are provided.
|
|
| Locked | Locked | Locked |
Generic drugs and clinical research services are provided globally.
|
|
| Locked | Locked | Locked |
Laboratory testing, clinical trial research, and biopharma services are provided.
|
|
| Locked | Locked | Locked |
AI powered scientific data management and workflow automation solutions
|
Detailed competitors of Caponex Labs
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Caponex Labs
Complete news archive for Caponex Labs
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Caponex Labs
Caponex Labs was founded in 2020 and raised its 1st funding round 3 years after it was founded.
Caponex Labs is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Caponex Labs is a funded company, having raised a total of $278.67K across 1 funding round to date.
As of Apr 10, 2024, the latest employee count at Caponex Labs is 1.
Annual revenue of Caponex Labs is $317.22K as on Mar 31, 2023.
Caponex Labs was established in 2020 in Hyderabad, India, within the pharmaceutical analytical services sector. Analytical method development, validation, quality control, and formulation analysis are offered, encompassing microbiological studies, release testing, trace metal analysis, impurity profiling, dissolution profiles, extractable analysis, physicochemical characterization, and stability testing. Operations adhere to safety and regulatory standards across these areas.
Caponex Labs has 2 investors. Key investors include Balvinder Singh Thakkar, and Ravinder Singh Thakkar.